The trade-off of a long drug-eluting stent.
作者信息
Kaul Upendra, Bhatia Vineet
机构信息
Batra Hospital and Medical Research Centre, New Delhi, India.
出版信息
EuroIntervention. 2021 Mar 19;16(16):1297-1298. doi: 10.4244/EIJV16I16A232.
Abstract
摘要
相似文献
1
The trade-off of a long drug-eluting stent.长效药物洗脱支架的权衡
EuroIntervention. 2021 Mar 19;16(16):1297-1298. doi: 10.4244/EIJV16I16A232.
2
Safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent in an all-comers population cohort.Yukon Choice Flex西罗莫司洗脱冠状动脉支架在所有患者人群队列中的安全性和有效性。
Indian Heart J. 2014 May-Jun;66(3):345-9. doi: 10.1016/j.ihj.2014.05.003.
3
Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries).在真实临床实践中（来自多中心前瞻性EXCELLENT和RESOLUTE - 韩国注册研究），第二代依维莫司洗脱Xience V支架与佐他莫司洗脱Resolute支架的三年患者相关及支架相关结局对比
Am J Cardiol. 2014 Nov 1;114(9):1329-38. doi: 10.1016/j.amjcard.2014.07.065. Epub 2014 Aug 12.
4
BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial.布马至尊生物可降解聚合物西罗莫司洗脱支架与耐用聚合物佐他莫司洗脱冠状动脉支架：先锋试验的三年临床结果
EuroIntervention. 2020 Dec 4;16(11):e900-e903. doi: 10.4244/EIJ-D-19-00566.
5
Drug-eluting stent treatment of left main coronary artery disease: the case for a sirolimus-eluting, autoexpandable alternative. An optical coherence tomography analysis.药物洗脱支架治疗左主干冠状动脉疾病：西罗莫司洗脱、自膨胀型替代支架的情况。光学相干断层扫描分析
Int J Cardiol. 2015 Nov 15;199:119-20. doi: 10.1016/j.ijcard.2015.07.006. Epub 2015 Jul 11.
6
Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.比较单纯血管造影方法与紫杉醇经皮冠状动脉介入治疗和心脏手术评分方法在左主干冠状动脉支架置入中的协同作用：系列 PRECOMBAT（使用依维莫司洗脱支架在左主干冠状动脉疾病患者中进行旁路手术与血管成形术的随机比较的首项研究）的汇总分析。
Circ Cardiovasc Interv. 2018 Jan;11(1):e005374. doi: 10.1161/CIRCINTERVENTIONS.117.005374.
7
Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).恩多雷佐塔鲁利姆洗脱支架与西罗莫司洗脱支架的长期临床和经济分析：来自 ENDEAVOR III 试验的 3 年结果（美敦力恩多雷药物[ABT-578]洗脱冠状动脉支架系统与西罗莫司洗脱冠状动脉支架系统在初发原生冠状动脉病变中的随机对照试验）。
JACC Cardiovasc Interv. 2009 Dec;2(12):1199-207. doi: 10.1016/j.jcin.2009.10.009.
8
Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents.经依维莫司洗脱支架置入术后冠状动脉瘤的病例系列研究及与西罗莫司洗脱支架的比较。
BMC Cardiovasc Disord. 2022 Feb 17;22(1):60. doi: 10.1186/s12872-022-02503-1.
9
Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial.无聚合物涂层西罗莫司和普罗布考洗脱支架与新一代佐他莫司洗脱支架治疗冠状动脉疾病的比较：冠状动脉支架置入术和血管造影结果：西罗莫司和普罗布考洗脱支架与佐他莫司洗脱支架疗效比较试验（ISAR-TEST 5）
Circulation. 2011 Aug 2;124(5):624-32. doi: 10.1161/CIRCULATIONAHA.111.026732. Epub 2011 Jul 18.
10
Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).晚期临床结果与佐他莫司和西罗莫司洗脱支架。ENDEAVOR III 试验（美敦力 Endeavor 药物 [ABT-578]洗脱冠状动脉支架系统与 Cypher 西罗莫司洗脱冠状动脉支架系统在初发原生冠状动脉病变中的随机对照试验）的 5 年随访结果。
JACC Cardiovasc Interv. 2011 May;4(5):543-50. doi: 10.1016/j.jcin.2010.12.014.
本文引用的文献
1
Clinical outcomes of long stenting in the drug-eluting stent era: patient-level pooled analysis from the GRAND-DES registry.药物洗脱支架时代长支架的临床结果：GRAND-DES 注册研究的患者水平汇总分析。
EuroIntervention. 2021 Mar 19;16(16):1318-1325. doi: 10.4244/EIJ-D-19-00296.
2
Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease.新一代超小径药物洗脱支架与上一代较厚支架药物洗脱支架治疗冠状动脉疾病的比较。
Circulation. 2018 Nov 13;138(20):2216-2226. doi: 10.1161/CIRCULATIONAHA.118.034456.
3
Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.XIENCE V依维莫司洗脱支架治疗超长病变PCI术后的临床结局；SPIRIT和XIENCE V美国前瞻性多中心试验的汇总分析
Catheter Cardiovasc Interv. 2017 May;89(6):984-991. doi: 10.1002/ccd.26711. Epub 2016 Aug 22.
4
Impact of ultra-long second-generation drug-eluting stent implantation.超长第二代药物洗脱支架植入的影响
Catheter Cardiovasc Interv. 2016 Feb 1;87(2):E44-53. doi: 10.1002/ccd.26010. Epub 2015 May 23.
5
Impact of the stent length on long-term clinical outcomes following newer-generation drug-eluting stent implantation.新一代药物洗脱支架置入后支架长度对长期临床结局的影响。
Am J Cardiol. 2014 Feb 1;113(3):457-64. doi: 10.1016/j.amjcard.2013.10.029. Epub 2013 Nov 9.
6
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.经皮冠状动脉介入治疗后病变长度和血管大小对临床结局的影响：来自 SPIRIT（依维莫司洗脱冠状动脉支架系统 XIENCE V 的临床评估）和 COMPARE（真实世界中第二代依维莫司洗脱和紫杉醇洗脱支架）随机试验的汇总分析。
JACC Cardiovasc Interv. 2011 Nov;4(11):1209-15. doi: 10.1016/j.jcin.2011.07.016.
7
The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.SYNTAX评分：一种对冠状动脉疾病复杂性进行分级的血管造影工具。
EuroIntervention. 2005 Aug;1(2):219-27.
8
The average stent length is longer and the average stent diameter is shorter in patients with drug-eluting stents versus bare-metal stents during percutaneous coronary intervention.在经皮冠状动脉介入治疗期间，与裸金属支架相比，药物洗脱支架患者的平均支架长度更长，平均支架直径更短。
Am J Ther. 2007 May-Jun;14(3):277-9. doi: 10.1097/MJT.0b013e3180653377.
9
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.药物洗脱支架血栓形成：一项纳入10项随机研究的汇总分析结果
J Am Coll Cardiol. 2005 Mar 15;45(6):954-9. doi: 10.1016/j.jacc.2004.11.065.
10
A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.最佳球囊血管成形术后对长冠状动脉病变进行额外支架置入术价值的随机对照研究：NIR支架治疗长冠状动脉病变附加价值（ADVANCE）研究的最终结果
J Am Coll Cardiol. 2002 Feb 6;39(3):393-9. doi: 10.1016/s0735-1097(01)01760-0.
Zotero 插件